• Molecular NameEthoxzolamide
  • SynonymEthoxazolamide; Ethoxyzolamide; Etoxzolamide
  • Weight258.322
  • Drugbank_IDDB00311
  • ACS_NO452-35-7
  • Show 2D model
  • LogP (experiment)2.01
  • LogP (predicted, AB/LogP v2.0)1.88
  • pka8.1
  • LogD (pH=7, predicted)1.85
  • Solubility (experiment)0.0241 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.47
  • LogSw (predicted, AB/LogsW2.0)0.09
  • Sw (mg/ml) (predicted, ACD/Labs)0.09
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds3
  • TPSA118.9
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA sulfonamide medication that functions as a carbonic anhydrase inhibitor. It is used in the treatment of glaucoma, duodenal ulcers, and as a diuretic. It may also be used in the treatment of some forms of epilepsy.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability65.0
  • Protein binding89.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life2.5~5.5 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A